Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Conditions: Chronic Myeloid Leukemia, Chronic Phase; Adult CML; Leukemia, Myeloid; Leukemia,Myeloid, Chronic Interventions: Drug: Asciminib; Drug: Ascimininb + Nilotinib Sponsors: Augusta University; H. Jean Khoury Cure CML Consortium Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials